Leerink Partners Maintains Outperform on Intuitive Surgical, Lowers Price Target to $573

Benzinga Newsdesk www.benzinga.com Negative 95.0%

Neg 95% Neu 0% Pos 0%

Leerink Partners analyst Mike Kratky maintains Intuitive Surgical (NASDAQ:ISRG) with a Outperform and lowers the price target from $622 to $573.